126 related articles for article (PubMed ID: 35810536)
21. Validated assay for the simultaneous determination of cortisol and budesonide in human plasma using ultra high performance liquid chromatography-tandem mass spectrometry.
Szeitz A; Manji J; Riggs KW; Thamboo A; Javer AR
J Pharm Biomed Anal; 2014 Mar; 90():198-206. PubMed ID: 24389462
[TBL] [Abstract][Full Text] [Related]
22. Determination of amphotericin B, liposomal amphotericin B, and amphotericin B colloidal dispersion in plasma by high-performance liquid chromatography.
Egger P; Bellmann R; Wiedermann CJ
J Chromatogr B Biomed Sci Appl; 2001 Sep; 760(2):307-13. PubMed ID: 11530990
[TBL] [Abstract][Full Text] [Related]
23. Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometry.
Ter Heine R; Hillebrand MJ; Rosing H; van Gorp EC; Mulder JW; Beijnen JH; Huitema AD
J Pharm Biomed Anal; 2009 Feb; 49(2):451-8. PubMed ID: 19128911
[TBL] [Abstract][Full Text] [Related]
24. LC-MS/MS determination of a human mAb drug candidate in rat serum using an isotopically labeled universal mAb internal standard.
Li W; Lin H; Fu Y; Flarakos J
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():166-176. PubMed ID: 28113139
[TBL] [Abstract][Full Text] [Related]
25. Determination of free and liposomal amphotericin B in human plasma by liquid chromatography-mass spectroscopy with solid phase extraction and protein precipitation techniques.
Deshpande NM; Gangrade MG; Kekare MB; Vaidya VV
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Feb; 878(3-4):315-26. PubMed ID: 20022309
[TBL] [Abstract][Full Text] [Related]
26. IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India.
Saha S; Mondal S; Ravindran R; Bhowmick S; Modak D; Mallick S; Rahman M; Kar S; Goswami R; Guha SK; Pramanik N; Saha B; Ali N
J Immunol; 2007 Oct; 179(8):5592-603. PubMed ID: 17911647
[TBL] [Abstract][Full Text] [Related]
27. Post-kala-azar dermal leishmaniasis with mucosal involvement in a kidney transplant recipient: treatment with liposomal amphotericin B.
Roustan G; Jiménez JA; Gutiérrez-Solar B; Gallego JL; Alvar J; Patrón M
Br J Dermatol; 1998 Mar; 138(3):526-8. PubMed ID: 9580814
[TBL] [Abstract][Full Text] [Related]
28. Determination of natamycin in rabbit cornea by high-performance liquid chromatography-tandem mass spectrometry with protective soaking extraction technology.
Tianyang Z; Ling Z; Huiyun X; Jijun H; Junjie Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Oct; 969():53-9. PubMed ID: 25151330
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B and C viral infections in Indian kala-azar patients receiving injectable anti-leishmanial drugs: a community-based study.
Singh S ; Kumar J; Singh R; Dwivedi SN
Int J Infect Dis; 2000; 4(4):203-8. PubMed ID: 11231183
[TBL] [Abstract][Full Text] [Related]
30. Determination of fascaplysin in rat plasma with ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS): application to a pharmacokinetic study.
Hu Z; Zhang M; He M; Fang B; Bao X; Yan X; Liang H; Wang H
J Pharm Biomed Anal; 2019 Jul; 171():126-131. PubMed ID: 30986762
[TBL] [Abstract][Full Text] [Related]
31. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
Das VN; Pandey K; Verma N; Lal CS; Bimal S; Topno RK; Singh D; Siddiqui NA; Verma RB; Das P
Am J Trop Med Hyg; 2009 Mar; 80(3):336-8. PubMed ID: 19270277
[TBL] [Abstract][Full Text] [Related]
32. Development of post-kala-azar dermal leishmaniasis in AmBisome treated visceral leishmaniasis: a possible challenge to elimination program in India.
Das VN; Pandey K; Singh D; Forwood C; Lal CS; Das P
J Postgrad Med; 2013; 59(3):226-8. PubMed ID: 24029204
[TBL] [Abstract][Full Text] [Related]
33. Development and validation of a liquid chromatographic-tandem mass spectrometric method for the multiplexed quantification of etravirine, maraviroc, raltegravir, and rilpivirine in human plasma and tissue.
Parsons TL; Marzinke MA
J Pharm Biomed Anal; 2016 Nov; 131():333-344. PubMed ID: 27632783
[TBL] [Abstract][Full Text] [Related]
34. Acute uveitis: A rare adverse effect of miltefosine in the treatment of post-kala-azar dermal leishmaniasis.
Pandey K; Pal B; Topno RK; Lal CS; Das VNR; Das P
Rev Soc Bras Med Trop; 2020; 54():e20200208. PubMed ID: 33338118
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of an LC-MS/MS method for the quantitative analysis of milciclib in human and mouse plasma, mouse tissue homogenates and tissue culture medium.
Martínez-Chávez A; Tibben MM; Broeders J; Rosing H; Schinkel AH; Beijnen JH
J Pharm Biomed Anal; 2020 Oct; 190():113516. PubMed ID: 32784092
[TBL] [Abstract][Full Text] [Related]
36. A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of paclitaxel and 6α-hydroxy-paclitaxel in human plasma: Development, validation and application in a clinical pharmacokinetic study.
Posocco B; Buzzo M; Follegot A; Giodini L; Sorio R; Marangon E; Toffoli G
PLoS One; 2018; 13(2):e0193500. PubMed ID: 29474420
[TBL] [Abstract][Full Text] [Related]
37. New high-performance liquid chromatographic method for amphotericin B analysis using an internal standard.
Lambros MP; Abbas SA; Bourne DW
J Chromatogr B Biomed Appl; 1996 Oct; 685(1):135-40. PubMed ID: 9026302
[TBL] [Abstract][Full Text] [Related]
38. Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme.
Hossain MS; Kumar A; Hossain AFMA; Mahshin M; Sharma A; Hossain MA; Sharma V; Haque R; Shamsuzzaman AKM; Maruf S; Ghosh P; Ahuja V; Mondal D
Infect Dis Poverty; 2018 Aug; 7(1):80. PubMed ID: 30099967
[TBL] [Abstract][Full Text] [Related]
39. A rapid and robust UHPLC-DAD method for the quantification of amphotericin B in human plasma.
Barco S; Zunino A; D'Avolio A; Barbagallo L; Maffia A; Tripodi G; Castagnola E; Cangemi G
J Pharm Biomed Anal; 2017 May; 138():142-145. PubMed ID: 28199895
[TBL] [Abstract][Full Text] [Related]
40. Quantification and pharmacokinetic study of entrectinib in rat plasma using ultra-performance liquid chromatography tandem mass spectrometry.
Wang Q; Fang P; Zheng L; Ye L
Biomed Chromatogr; 2019 Apr; 33(4):e4467. PubMed ID: 30549079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
